Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Hakuo Ikegami"'
Autor:
Norie Arai, Harumi Ariyasu, Shigeto Yamamoto, Tsunetaka Ohta, Masao Ikeda, Tadao Tanimoto, Masashi Kurimoto, Toshio Ariyasu, Shigeharu Fukuda, Hakuo Ikegami, Noboru Fujioka
Publikováno v:
Biomedical Research. 27:219-226
While interferon-alpha (IFN-alpha) subtypes share a common specific receptor composed of two subunits, interferon-alpha receptor (IFNAR)-1 and IFNAR-2, their subtype activities are exhibited via several intracellular signaling pathways and thus subse
Autor:
Takeshi Tanaka, Masashi Kurimoto, Masao Ikeda, Hakuo Ikegami, Hiroshi Yamauchi, Yoshiaki Yanai, Shigeto Yamamoto, Noboru Fujioka, Toshio Ariyasu, Kunzo Orita
Publikováno v:
Biomedical Research. 25:75-82
Enhanced T helper 1 (Th1)-type immunity was observed in patients with hepatitis C virus (HCV) infection during investigations on the efficiency of interferon (IFN) therapy. The mechanism for the shift to Th1-type immunity is, however, obscure in HCV
Autor:
Toshio Ariyasu, Noboru Fujioka, Hakuo Ikegami, Hiroshi Yamauchi, Masashi Kurimoto, Shigeto Yamamoto, Takeshi Tanaka, Yoshiaki Yanai, Masao Ikeda
Publikováno v:
Biomedical Research. 24:231-237
T helper (Th) cells have been characterized into two subsets, Th1 and Th2, by the pattern of cytokine secretion. Generally, Th1 type cells mediate cellular immune responses and Th2 type cells mediate humoral immunity. Recently, Thl type immunity is t
Autor:
Osamu Sanou, Kouzou Yamamoto, Masashi Kurimoto, Yoshiaki Yanai, Hiroshi Yamauchi, Hakuo Ikegami
Publikováno v:
Cancer Letters. 185:173-179
Here we report on the anti-tumor effects of five interferon (IFN)-alpha subtypes, alpha1, alpha2, alpha5, alpha8, and alpha10 in chronic myelogenous leukaemia (CML)-derived cell lines. All of the CML cells can respond to IFN-alpha although the anti-t
Autor:
Osamu Sanou, Masashi Kurimoto, Hakuo Ikegami, Shigeto Yamamoto, Hirohisa Yano, Masamichi Kojiro
Publikováno v:
Hepatology Research. 24:99-106
We have studied the antiviral activities of five recombinant interferon-alpha (IFN-alpha) subtypes, namely IFN-alpha1, -alpha2, -alpha5, -alpha8 and -alpha10, in eight human liver cancer cell lines. The relative antiviral activities, expressed in ter
Autor:
Kouzou Yamamoto, Tadaichi Kitamura, Hakuo Ikegami, Hiroshi Yamauchi, Masashi Kurimoto, Shigeo Horie, Yoshiaki Yanai
Publikováno v:
Journal of Interferon & Cytokine Research. 21:1129-1136
Interferon-alpha (IFN-alpha) has a number of therapeutic applications in the treatment of various human cancers and diseases of viral origin. IFN-alpha includes several subtypes, and little has been reported on the biologic properties of the individu
Autor:
Masashi Kurimoto, Kenji Akita, Tetsuya Mori, Makoto Takeuchi, Hakuo Ikegami, Masao Ikeda, Takanori Okura, Tsunetaka Ohta
Publikováno v:
Cell and Tissue Research. 297:467-473
Interleukin-18 is a novel multifunctional cytokine, which enhances natural killer cell activity and promotes the induction of cytokine production, including that of interferon-gamma by T cells and antitumor effects. Interleukin-18 is produced by cell
Autor:
Yasushi Aizawa, Masashi Kurimoto, Kazue Tsuji-Takayama, Iwao Okamoto, Tsunetaka Ohta, Kazuhiro Koide, Hirotada Kojima, Hakuo Ikegami, Makoto Takeuchi
Publikováno v:
Cellular Immunology. 196:41-50
Interleukin-18 (IL-18) combined with anti-CD3 monoclonal antibody (mAb) induced interferon-gamma (IFN-gamma) production by T helper type 1 (Th1) cells. Neither IL-18 nor anti-CD3 mAb alone induced production of IFN-gamma. Although treatment with IL-1
Autor:
Hirotada Kojima, Yasushi Aizawa, Yoshiaki Yanai, Katsue Nagaoka, Makoto Takeuchi, Tsunetaka Ohta, Hakuo Ikegami, Masao Ikeda, Masashi Kurimoto
Publikováno v:
The Journal of Immunology. 162:5063-5069
IL-18 is a multifunctional cytokine playing various regulatory roles in the immune system including induced cytokine production. As a part of our ongoing studies on the molecular mechanisms of IL-18-induced IFN-γ production, we have examined the tra
Autor:
Kakuji Torigoe, Masashi Kurimoto, Mark Micallef, Tadao Tanimoto, Yoshihiro Nishida, Hakuo Ikegami, Keizo Kohno
Publikováno v:
Cancer Immunology, Immunotherapy. 48:109-117
Interleukin-18 (IL-18) enhances interferon gamma (IFNgamma) production and natural killer (NK) cell activity, and elicits protective antitumor effects in vivo. IL-18 and IL-12 synergistically augment IFNgamma production reportedly because IL-12 enhan